AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,248,000 | -24.0% | 55,361 | +17.3% | 0.40% | -7.7% |
Q4 2016 | $1,643,000 | -5.2% | 47,214 | -33.3% | 0.44% | +5.8% |
Q3 2016 | $1,734,000 | +508.4% | 70,759 | +493.9% | 0.42% | +698.1% |
Q2 2016 | $285,000 | -68.7% | 11,915 | -69.3% | 0.05% | -60.3% |
Q1 2016 | $910,000 | -52.5% | 38,870 | -19.4% | 0.13% | -29.2% |
Q3 2015 | $1,915,000 | +38.8% | 48,211 | +141.3% | 0.18% | +37.0% |
Q2 2015 | $1,380,000 | +95.5% | 19,976 | +54.8% | 0.14% | +95.7% |
Q1 2015 | $706,000 | -30.2% | 12,908 | -75.3% | 0.07% | +3.0% |
Q1 2014 | $1,011,000 | -1.7% | 52,253 | +23.4% | 0.07% | +39.6% |
Q4 2013 | $1,028,000 | +0.1% | 42,357 | -11.4% | 0.05% | +2.1% |
Q3 2013 | $1,027,000 | +5.8% | 47,831 | +9.7% | 0.05% | +14.6% |
Q2 2013 | $971,000 | – | 43,618 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |